TOP 10: Biotech stocks being bought and sold by billionaires right now
Biotech and health care stocks continue to be some of the most popular to watch, and the wave of consolidations in the health and pharma space is attracting top hedge fund billionaires.
Forbes recently compiled a list of the 20 biotech and health care stocks the richest hedge fund billionaires are looking at based on the number of billionaires who either bought or sold the stock in at least 10,000 shares.
RELATED TOPIC: 3 stocks to watch in the US medical marijuana market
The year 2015 saw a sharp increase in the number of M&A deals, and the events shifted the interest in certain stocks. The anticipation of more deals to come drew “votes of confidence” for targets such as Teva Pharmaceutical. Actavis, however, is on both the top selling and buying list as hedge fund billionaires can’t seem to agree with the most widely held stock among U.S. hedge funds.
Actavis is 24 percent owned by hedge funds. The debate on whether to buy or sell this stock stems from the merger between the Dublin-based drug giant and Botox maker Allergan.
RELATED TOPIC: The 3 most expensive pharmaceutical mergers and acquisitions
HCA Holdings comes at No. 1 on Forbes’ list, as nine hedge fund billionaires cut back their positions at the end of Q1 after the hospital operator’s positive stock return over the past year. The stock, however, jumped 9 percent in June as the Supreme Court ruled to uphold an important part of the Affordable Care Act, benefitting hospital operations.
RELATED TOPIC: Anthem to become largest US health insurer after $54B Cigna acquisition
To see the complete list, visit Forbes.
- Kroll’s Andreas Chrysostomou on the future of life sciencesTechnology & AI
- People moves: Neovii, Novant Health, Laguna HealthDigital Healthcare
- Biosample Hub: tackling the crisis in biotech researchMedical Devices & Pharma
- Why Novo Nordisk is buying biotech firm CorvidiaMedical Devices & Pharma